Detalhe da pesquisa
1.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Blood
; 143(16): 1565-1575, 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38252906
2.
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Blood
; 142(26): 2327-2331, 2023 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37738563
3.
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax.
Haematologica
; 109(1): 186-199, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37534528
4.
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Ann Hematol
; 103(1): 185-198, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37851072
5.
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Br J Haematol
; 203(5): 774-780, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37584155
6.
The treatment of Burkitt lymphoma in adults.
Blood
; 137(6): 743-750, 2021 02 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33171490
7.
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study.
Lancet Oncol
; 22(10): 1391-1402, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34534514
8.
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
Blood
; 134(11): 860-866, 2019 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31320380
9.
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.
Blood
; 133(6): 566-575, 2019 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30498064
10.
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.
Blood
; 134(1): 22-29, 2019 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30952672
11.
The future of antibody therapy in chronic lymphocytic leukemia.
Expert Opin Emerg Drugs
; 26(3): 323-336, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34375544
12.
Current considerations in AYA Hodgkin lymphoma.
Br J Haematol
; 184(1): 72-81, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30460695
13.
Classifying DLBCL Subtypes for Optimal Treatment.
Oncology (Williston Park)
; 33(10)2019 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31661151
14.
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy.
Haematologica
; 108(12): 3433-3437, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37259597
15.
Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival.
Biol Blood Marrow Transplant
; 23(1): 113-118, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27789360
16.
17.
IGHV mutational status testing in chronic lymphocytic leukemia.
Am J Hematol
; 92(12): 1393-1397, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28589701
18.
Monotypic plasmacytoid cells mimicking lymph node malignancy in the setting of COVID-19 recovery.
Am J Hematol
; 97(5): 666-667, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34779014
19.
A multicenter, retrospective study of accelerated venetoclax ramp-up in patients with relapsed/refractory chronic lymphocytic leukemia.
Am J Hematol
; 97(3): E105-E109, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34929063
20.
Venetoclax for the treatment of patients with chronic lymphocytic leukemia.
Future Oncol
; 13(14): 1223-1232, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28492339